Search results
Found 6785 matches for
Results from the ATOM clinical trial at the University of Oxford have shown that the anti-malarial drug Atovaquone can reduce very low oxygen tumour environments. This has the potential to make cancers behave less aggressively and to improve the impact of everyday cancer treatments.
Population, Global, and Public Health
Population and global health research generates evidence that reliably answers important questions about human health.